Ebstein's anomaly in a beagle dog.
An intact male beagle dog aged 1 year was referred because of shortness of breath, exercise intolerance and cardiac murmur. Based on the results from electrocardiography, thoracic radiography and echocardiography, the dog was diagnosed as Ebstein's anomaly. Although the orally administered digoxin, vasodilators and diuretics partially improved congestive signs, the dog became to be refractory and died 20 months after the diagnosis. Necropsy confirmed malformation and apical displacement of the basal attachment of tricuspid valve leaflets.
Takemura
Naoyuki
N
Department of Veterinary Internal Medicine, Nippon Veterinary and Animal Science University, Kyonan-cho, Musashino City, Tokyo, Japan.
Machida
Noboru
N
Nakagawa
Kiyoshi
K
Amasaki
Hajime
H
Washizu
Makoto
M
Hirose
Hisashi
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002037:Bundle-Branch Block / Q000209:etiology / Q000662:veterinary; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004039:Diet, Sodium-Restricted / Q000662:veterinary; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004285:Dogs / Q000002:abnormalities*; D004359:Drug Therapy, Combination; D004437:Ebstein Anomaly / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D004452:Echocardiography / Q000662:veterinary; D004562:Electrocardiography / Q000662:veterinary; D004656:Enalapril / Q000627:therapeutic use; D017809:Fatal Outcome; D005665:Furosemide / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008297:Male; D013148:Spironolactone / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents; D013148:Spironolactone; D004656:Enalapril; D004077:Digoxin; D005665:Furosemide; D007548:Isosorbide Dinitrate